Orion Biotech Opportunities Corp. Annual Operating Income (Loss) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Orion Biotech Opportunities Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2022.
  • Orion Biotech Opportunities Corp. Operating Income (Loss) for the quarter ending December 31, 2022 was -$204K, a 31.1% increase year-over-year.
  • Orion Biotech Opportunities Corp. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$900K, a 43.2% decline year-over-year.
  • Orion Biotech Opportunities Corp. annual Operating Income (Loss) for 2022 was -$900K, a 43.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$900K -$271K -43.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-29
2021 -$628K Feb 5, 2021 Dec 31, 2021 10-K 2023-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.